We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Pulse Biosciences Inc | NASDAQ:PLSE | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.23 | -2.86% | 7.82 | 7.00 | 13.25 | 8.23 | 7.73 | 8.05 | 169,447 | 05:00:01 |
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced plans to participate in two upcoming virtual investor conferences.
Management is scheduled to participate in the H.C. Wainwright Global Life Sciences Conference hosting one-on-one meetings Wednesday, March 10, 2021. A presentation webcast will be available in advance of the event on Tuesday, March 9, 2021 at 7:00am ET.
Management is scheduled to participate in an aesthetic dermatology panel discussion during the Maxim Emerging Growth Virtual Conference on Wednesday, March 17, 2021. A live and recorded webcast of the panel discussion will be available at 2:00pm ET on the same day. A presentation by management will also be available at the start of the event at 9:00am ET on Wednesday, March 17, 2021.
Interested parties may access the on-demand webcasts from both conferences on the “Investors” section of the Company’s website at www.pulsebiosciences.com.
About Pulse Biosciences®
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The CellFX® System is the first commercial product to harness the distinctive advantages of the Company’s proprietary Nano-Pulse Stimulation™ (NPS™) technology, such as the ability to non-thermally clear cells while sparing non-cellular tissue, to treat a variety of applications for which an optimal solution remains unfulfilled. Nano-Pulse Stimulation technology delivers nano-second pulses of electrical energy. The initial commercial use of the CellFX System is to address a range of dermatologic conditions that share high demand among patients and practitioners for improved dermatologic outcomes. Designed as a multi-application platform, the CellFX System offers customer value with a utilization-based revenue model. To learn more, please visit pulsebiosciences.com.
To stay informed about the CellFX System, please visit CellFX.com and sign up for updates.
Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210305005107/en/
Investors: Pulse Biosciences Sandra Gardiner, EVP and CFO 510.241.1077 IR@pulsebiosciences.com or Gilmartin Group Philip Trip Taylor 415.937.5406 philip@gilmartinir.com
Media: Tosk Communications Nadine D. Tosk 504.453.8344 nadinepr@gmail.com or press@pulsebiosciences.com
1 Year Pulse Biosciences Chart |
1 Month Pulse Biosciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions